ZHYBF — Zhong Yuan Bio-Technology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $0.00m
- $1.73m
- $2.28m
Annual cashflow statement for Zhong Yuan Bio-Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | C2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.087 | -0.028 | -0.683 | -1.67 | 0.272 |
| Depreciation | |||||
| Non-Cash Items | 0.014 | 0.176 | 0.372 | 0.402 | 0.121 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.079 | 0.155 | 0.052 | 0.238 | -1.14 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.147 | 0.309 | -0.253 | -1.03 | -0.746 |
| Capital Expenditures | -0.008 | -0.006 | -0.002 | -0.022 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.124 | 0.005 | 0 | 0.141 | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.131 | -0.001 | -0.002 | 0.118 | 0 |
| Financing Cash Flow Items | 0.082 | -0.299 | 0.098 | 0.701 | 0.123 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.351 | -0.096 | 0.263 | 1.3 | 0.715 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.055 | 0.134 | -0.093 | 0.176 | -0.133 |